Clinical trial
Iron-Chelating Therapy and Friedreich Ataxia
NCT00224640 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00224640 |
|---|---|
| Title | Iron-Chelating Therapy and Friedreich Ataxia |
| Official title | Effect of Iron-Chelating Therapy in Friedreich Ataxia. Study Phase I/II |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Friedreich Ataxia |
| Intervention type | Drug |
| Interventions | Iron chelating intervention |
| Enrollment | 15 |
| Start date | Mar 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 23, 2005 |
| Last update posted | Mar 4, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: